MMP activity with disruption of structural collagen has been implicated in the pathophysiology of dilated cardiomyopathy. To examine the role of this enzyme in cardiac function, a transgenic mouse was created that constitutively expressed human collagenase (MMP-1) in the heart. At 6 months of age, these animals demonstrated compensatory myocyte hypertrophy with an increase in the cardiac collagen concentration due to elevated transcription of type III collagen. Chronic myocardial expression of MMP-1 produced loss of cardiac interstitial collagen coincident with a marked deterioration of systolic and diastolic function at 12 months of age. This is the first animal model demonstrating that direct disruption of the extracellular matrix in the heart reproduces the changes observed in the progression of human heart failure.
Henry E. Kim, Seema S. Dalal, Erik Young, Marianne J. Legato, Myron L. Weisfeldt, Jeanine D’Armiento
Title and authors | Publication | Year |
---|---|---|
Mmp1a and Mmp1b are not functional orthologs to human MMP1 in cigarette smoke induced lung disease
PI Carver, V Anguiano, JM D’Armiento, T Shiomi |
Experimental and Toxicologic Pathology | 2014 |
Remodelling the extracellular matrix in development and disease
C Bonnans, J Chou, Z Werb |
Nature Reviews Molecular Cell Biology | 2014 |
Impairment of Myocardial Mitochondria in Viral Myocardial Disease and Its Reflective Window in Peripheral Cells
J Wei, DF Gao, H Wang, R Yan, ZQ Liu, ZY Yuan, J Liu, MX Chen, R Morishita |
PloS one | 2014 |